The COVID-19 pandemic is shaking the whole world and except for China, this deadly virus didn’t show any mercy on the other countries. The cases are being registered in record levels especially in India, and in a day or two, the COVID-19 cases may breach the 10,000 mark a day with this rate of infection.
Now, the people’s only hope is the release of a potent vaccine in the market to treat this deadly virus. But, it will at least take a year to complete all the clinical trials and pass all the safety guidelines recommended by the health care authorities.
Now, the Indian health organization which is based on the Ayurvedic supplies is looking to formulate a medicine at the earliest. Dalmia Healthcare on Thursday said it has started clinical trials to evaluate the efficacy and safety of its polyherbal combination ‘Astha-15’ for treatment of COVID-19.
“We are conducting human trials of our highly efficient ayurvedic composition which can potentially help in curing COVID-19 patients,” Sanjay Dalmia said. As we all know, there is the least possibility of the side effects in Ayurvedic science unlike allopathy and this drug acts as a bronchodilator, decongestant, anti-inflammatory, lung detoxifier.